Cempra Pharmaceuticals company information, Employees & Contact Information

With Melinta Merger, Cempra Lands on Its Feet Despite Regulatory Struggles Pharmaceutical Technology

Cempra and Melinta Announce Merger to Form Leading, GlobeNewswire

Melinta grows pipeline through reverse merger with Cempra BioPharma Dive

Another setback for Cempra’s solithromycin, this time in gonorrhea Fierce Biotech

Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL) The Lancet

Concerns at Wockhardt, Hospira plants factor into CRL issued to Cempra Fierce Pharma

Cempra Seals Merger Deal With This Antibiotics Biopharmaceutical BioSpace

FDA Rejects NDAs for Cempra Bacterial Pneumonia Candidate Solithromycin Genetic Engineering and Biotechnology News

Cempra, Melinta to Merge Into New Commercial Stage Anti-Infectives Firm drugdiscoverytrends.com

Cempra hopes for antibiotics blockbuster dashed Business North Carolina

Cempra Plans $100 Mln Public Offering RTTNews

Cempra pulls European marketing application for antibiotic BioPharma Dive

Cempra pulls EU antibiotic filing following EMA questioning Fierce Biotech

Wockhardt problems could delay approval of Cempra's antibiotic Fierce Pharma

Cempra’s Fusidic Acid Antibiotic Meets Phase III Endpoints for Treating ABSSSI Genetic Engineering and Biotechnology News

After FDA delays pneumonia antibiotic, Cempra’s shares plummet BioPharma Dive

Melinta merges with faltering Cempra, bagging a Nasdaq listing and a pipeline of anti-infective programs Fierce Biotech

Cempra drug narrowly wins support of FDA panel BioPharma Dive

FDA panel, by a whisker, votes yes on Cempra’s antibiotic Fierce Biotech

Cempra hit with FDA delay as manufacturing, safety issues blight antibiotic Fierce Biotech

New Antibiotics Promising in Pneumonia, Abdominal Infection Medscape

Chapel Hill drug developer Cempra looks to raise $200M The Business Journals

Next-generation Cempra antibiotic meets endpoints Pharmafile

Aisling Capital Reduces Stake in Cempra Inc (CEMP) Insider Monkey